Clinical Trial Update: Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating stereotactic radiotherapy plus temozolomide for refractory brain metastases has completed. The trial was conducted by the Chinese Aca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Brain Metastases | Phase 2 | Status: COMPLETED